CA2980957C - Composition, particulate materials and methods for making particulate materials. - Google Patents
Composition, particulate materials and methods for making particulate materials. Download PDFInfo
- Publication number
- CA2980957C CA2980957C CA2980957A CA2980957A CA2980957C CA 2980957 C CA2980957 C CA 2980957C CA 2980957 A CA2980957 A CA 2980957A CA 2980957 A CA2980957 A CA 2980957A CA 2980957 C CA2980957 C CA 2980957C
- Authority
- CA
- Canada
- Prior art keywords
- silica
- shell
- nanoparticles
- particles
- carbon
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
- C01B32/00—Carbon; Compounds thereof
- C01B32/15—Nano-sized carbon materials
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
- A01N25/26—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests in coated particulate form
- A01N25/28—Microcapsules or nanocapsules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/5115—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/14—Ectoparasiticides, e.g. scabicides
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/02—Making microcapsules or microballoons
- B01J13/06—Making microcapsules or microballoons by phase separation
- B01J13/14—Polymerisation; cross-linking
- B01J13/18—In situ polymerisation with all reactants being present in the same phase
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/02—Making microcapsules or microballoons
- B01J13/20—After-treatment of capsule walls, e.g. hardening
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/02—Making microcapsules or microballoons
- B01J13/20—After-treatment of capsule walls, e.g. hardening
- B01J13/203—Exchange of core-forming material by diffusion through the capsule wall
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/02—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material
- B01J20/10—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material comprising silica or silicate
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/28—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties
- B01J20/28002—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties characterised by their physical properties
- B01J20/28004—Sorbent size or size distribution, e.g. particle size
- B01J20/28007—Sorbent size or size distribution, e.g. particle size with size in the range 1-100 nanometers, e.g. nanosized particles, nanofibers, nanotubes, nanowires or the like
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/28—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties
- B01J20/28014—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties characterised by their form
- B01J20/28016—Particle form
- B01J20/28021—Hollow particles, e.g. hollow spheres, microspheres or cenospheres
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/28—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties
- B01J20/28054—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties characterised by their surface properties or porosity
- B01J20/28057—Surface area, e.g. B.E.T specific surface area
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
- B01J20/3291—Characterised by the shape of the carrier, the coating or the obtained coated product
- B01J20/3293—Coatings on a core, the core being particle or fiber shaped, e.g. encapsulated particles, coated fibers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y40/00—Manufacture or treatment of nanostructures
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
- C01B33/00—Silicon; Compounds thereof
- C01B33/113—Silicon oxides; Hydrates thereof
- C01B33/12—Silica; Hydrates thereof, e.g. lepidoic silicic acid
- C01B33/18—Preparation of finely divided silica neither in sol nor in gel form; After-treatment thereof
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01M—PROCESSES OR MEANS, e.g. BATTERIES, FOR THE DIRECT CONVERSION OF CHEMICAL ENERGY INTO ELECTRICAL ENERGY
- H01M4/00—Electrodes
- H01M4/02—Electrodes composed of, or comprising, active material
- H01M4/36—Selection of substances as active materials, active masses, active liquids
- H01M4/58—Selection of substances as active materials, active masses, active liquids of inorganic compounds other than oxides or hydroxides, e.g. sulfides, selenides, tellurides, halogenides or LiCoFy; of polyanionic structures, e.g. phosphates, silicates or borates
- H01M4/581—Chalcogenides or intercalation compounds thereof
- H01M4/5815—Sulfides
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01M—PROCESSES OR MEANS, e.g. BATTERIES, FOR THE DIRECT CONVERSION OF CHEMICAL ENERGY INTO ELECTRICAL ENERGY
- H01M4/00—Electrodes
- H01M4/02—Electrodes composed of, or comprising, active material
- H01M4/62—Selection of inactive substances as ingredients for active masses, e.g. binders, fillers
- H01M4/624—Electric conductive fillers
- H01M4/625—Carbon or graphite
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01M—PROCESSES OR MEANS, e.g. BATTERIES, FOR THE DIRECT CONVERSION OF CHEMICAL ENERGY INTO ELECTRICAL ENERGY
- H01M4/00—Electrodes
- H01M4/02—Electrodes composed of, or comprising, active material
- H01M4/64—Carriers or collectors
- H01M4/66—Selection of materials
- H01M4/663—Selection of materials containing carbon or carbonaceous materials as conductive part, e.g. graphite, carbon fibres
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2004/00—Particle morphology
- C01P2004/30—Particle morphology extending in three dimensions
- C01P2004/32—Spheres
- C01P2004/34—Spheres hollow
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2004/00—Particle morphology
- C01P2004/60—Particles characterised by their size
- C01P2004/61—Micrometer sized, i.e. from 1-100 micrometer
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2004/00—Particle morphology
- C01P2004/60—Particles characterised by their size
- C01P2004/62—Submicrometer sized, i.e. from 0.1-1 micrometer
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2006/00—Physical properties of inorganic compounds
- C01P2006/16—Pore diameter
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01M—PROCESSES OR MEANS, e.g. BATTERIES, FOR THE DIRECT CONVERSION OF CHEMICAL ENERGY INTO ELECTRICAL ENERGY
- H01M4/00—Electrodes
- H01M4/02—Electrodes composed of, or comprising, active material
- H01M4/13—Electrodes for accumulators with non-aqueous electrolyte, e.g. for lithium-accumulators; Processes of manufacture thereof
- H01M4/134—Electrodes based on metals, Si or alloys
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
- Y02E60/00—Enabling technologies; Technologies with a potential or indirect contribution to GHG emissions mitigation
- Y02E60/10—Energy storage using batteries
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nanotechnology (AREA)
- Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Materials Engineering (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Dispersion Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Electrochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Physics & Mathematics (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Optics & Photonics (AREA)
- Biomedical Technology (AREA)
- Manufacturing & Machinery (AREA)
- Composite Materials (AREA)
- Environmental Sciences (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Toxicology (AREA)
- Dentistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Silicon Compounds (AREA)
Abstract
Description
Composition, particulate materials and methods for making particulate materials.
TECHNICAL FIELD
[0001] The present invention relates to particulate materials and to methods for forming particulate materials. The present invention also relates to a composition.
The present invention also relates to a composition containing hydrophobic compounds; and/or a composition with hydrophobic properties. Some of the particulate material may be used in compositions in accordance with aspects of the invention.
BACKGROUND ART
The export of red meat and livestock contributed a total value of - $16 billion in 2012 -2013. However, arthropod pests pose a serious threat to the industry. It is estimated that ticks cost the cattle industry around $170-200 million each year. Furthermore, buffalo fly and sheep lice infestations have caused millions of dollars in losses due to the cost of implementing control strategies and lost productivity. The high cost of ectoparasite treatment is primarily due to the high dose rates and repeated treatments of active compounds required to achieve efficacy.
Moreover, many pesticides currently in use have high toxicity, negative environmental effects and potential risks to human health and food safety. Arthropod pests are equally threatening to plant crops such as cereals, vegetables and fruit.
instability which reduces potency, low water solubility and hydrophobicity, making formulation in aqueous systems difficult and higher cost relative to conventional chemical pesticides. Spinosad is currently registered for use in sheep to treat lice and fly infestations, however, its reduced potency and duration of efficacy against ectoparasites of cattle has prevented its registration as a treatment for buffalo fly and cattle tick. Likewise, these drawbacks have limited Spinosad's use in crop protection applications where aqueous formulations are commonly used and UV stability is required by pesticides that reside on plant surfaces following application.
Suspensions or emulsions can suffer from short shelf life, due to a tendency to separate into separate layers.
Application via spraying can also be difficult for the same reason. Further difficulties are encountered if the compounds are sensitive to light or ultraviolet light. In such circumstances, the compounds can have a short period of effectiveness following application due to the compound breaking down when exposed to sunlight.
light including topical formulations used for humans and animals and those used in crop protection. The ability to formulate these active molecules into a UV
protecting carrier system could enable longer duration of effectiveness.
vaccination is a most recent form of treatment, where a plasmid DNA (p-DNA) encoding an antigen of interest is delivered into cells to induce antigen-specific immunity. Here, rather than injecting a patient with a vaccine antigen as is commonly done in the cases of vaccination using sub-unit vaccines, patients are injected with p-DNA molecules that provide the body's cells with the code to produce the antigen in vivo, effectively allowing the body to produce its own antigen.
Vaccination strategies using other nucleic acid forms such as messenger RNA
(mRNA) are also emerging.
However poor immunogenicity is a major problem and a significant cause of this is the inability of the p-DNA
to be effectively delivered to the cell nucleus so that the DNA can be incorporated to then produce the vaccine antigen. Inefficient delivery of p-DNA is caused by three main factors, all of which combined mean that only a small proportion of p-DNA injected into the body actually makes it into the cell nucleus to enable the production of vaccine antigens:
1. Breakdown of the p-DNA by nucleases after injection or delivery into the body and before the p-DNA enters the cell 2. Inability to be efficiently transported across the cell membrane into the cell 3. Inability to efficiently enter the cell nucleus once inside the cell
Since then, polymer microspheres and cationic liposomes have emerged as two promising new delivery technologies, although neither likely is good enough to allow DNA vaccines to be widely adopted.
and loading is easy so that the p-DNA is not damaged during the process. Protection against nucleases is good since the p-DNA can be encapsulated within the liposome. However the liposomes are soft particles and so are not very stable in vivo. Toxicity is also of great concern. Polymer microparticles are also used as a carrier for p-DNA. The polymers are typically more rigid than liposomes so do not have the tendency to mechanically degrade in vivo. Polymer microparticles also provide good protection for the p-DNA against nucleases. However the key polymers that have been proposed (polylactic acid and poly(lactic-co-glycolic acid)) form hydrophobic particles and are negatively charged and so may not properly encapsulate the p-DNA. In addition, the loading methods are generally quite harsh, which may damage the p-DNA during processing. Transfection efficiency tends to be low. Polyethylenimine (PEI) has been shown to enable higher transfection efficiencies however these polymers can be extremely cytotoxic.
Understanding the unique loop structure of p-DNA molecules and rational design of advanced p-DNA delivery vehicles is highly desired for efficient gene therapy and DNA
vaccination strategies.
SUMMARY OF INVENTION
In other aspects of the present invention, particulate material and methods for forming particulate material are provided.
Projections which may have spherical or other shapes are present on the outside of the shell, providing a rough surface to the particles. Although the material from which the rough mesoporous hollow nanoparticles (such as silica) may normally be a hydrophilic material, the rough surface results in the rough mesoporous hollow nanoparticles exhibiting hydrophobic properties, thereby allowing or even enhancing movement of the hydrophobic compounds into the hollow core.
Alternatively, the spaced silica projections may comprise strands or cylinders or fibres or nodules extending outwardly from the hollow shell of the nanoparticles. The length of the projections may be from nm up to the diameter of the large hollow particle on which they reside, however they may be made longer if required by the application. The diameter of the projections may be as low as 2-3 nm or as high as 100 nm or higher and the diameter or thickness of a projection may vary along its length due to the process used to form it. The specific surface area of the nanoparticles may range from 100m2/g to 1000m2/g, or from 150 m2/g to 1000m2/g, or from 175 m2/g to 1000m2/g
Other hydrophobic pesticides that may be formulated with the particles of the present invention include, but are not limited to pyrethroid, azadirachtin (neem oil) and pyrethrum. Similar to Spinosad, these are natural products which are safe to use but breakdown quickly under sunlight.
Indeed, many new pharmaceutically active molecules currently under development suffer from problems of hydrophobicity or UV degradation and these are likely to be compatible with the particles of the present invention.
In one embodiment, the rough mesoporous hollow nanoparticles comprise rough mesoporous hollow silica nanoparticles.
During the manufacture and storage of enzyme formulations, many enzymes suffer degradation as a result of thermal breakdown, hydrolysis or otherwise, requiring excess enzyme to be used in formulations in order to compensate for these yield losses. For example, in the steam pelleting process used to make some animal feeds, the application of steam can result in denaturation of some of the enzyme content, requiring either excess enzyme to be added to the formulation or the use of expensive equipment to spray enzyme onto the resulting pellets following the steam pelleting process. Formulation of enzymes with the particles of the present invention can protect the enzyme from degradation. These active ingredients may be loaded into the internal cavity provided by the particles, on the outside of the particles entangled with the projections or a combination of both. How the active ingredient is distributed between the internal cavity and external surface depends of the desired rate of release, the size of the molecule, the desired loading level, the extent of protection needed by the active ingredient and other factors.
Accordingly, in a third aspect, the present invention provides a composition for providing sustained release of a compound, the composition comprising rough mesoporous hollow nanoparticles having compounds taken up therein. In this aspect, the compound may be a hydrophobic compound or may be a hydrophilic compound. The compound may comprise any of the materials described as being suitable for use in the first aspect of the present invention. The compound may be a therapeutic agent, such as an antibiotic. The antibiotic may be, for example, vancomycin or metronidazole.
In some embodiments, the active molecules may be any of the active molecules described herein.
(p-DNA) and messenger RNA (mRNA) that are used in emerging vaccination strategies. In the case of p-DNA, it is desirable to be able to protect the p-DNA molecule from attack by nucleases on entry of the p-DNA into the body. This mode of degradation of p-DNA is responsible for a significant reduction in the efficacy of DNA vaccines. Due to the large size of the p-DNA
molecules, when foimulated with the particles of the present invention p-DNA is largely distributed on the outside of the particles, secured by the projections on the surface of the particles.
This is sufficient to provide a high degree of protection against attack by nucleases. In foimulating a DNA or mRNA-based vaccine, the particles of the present invention may be coated with substances that increase the affinity of the particles to these nucleic acids. This may involve covalently grafting chemical functional groups onto the particles, or applying a coating that interacts with the particle surface via hydrogen bonding, electrostatic attraction or some other means known to those skilled in the art. For example, polyethylenimine (PEI) may be coated onto the particles.
With a formulation substantially stable against attack by nucleases, the next challenge for a DNA
vaccine delivery system is to efficiently cross the cell membrane carrying the p-DNA. . The size of the particles of the present invention is well-suited for efficient cellular uptake by host cells after foiming complexes with p-DNA, mRNA, siRNA or other nucleic acids. . In some instances, where the nucleic acid molecules are located on the outside of the shell, secured to the particles via entanglement in the projections, it may not be necessary to use a shell with any porosity since the active molecules do not substantially enter the internal cavity..
The core may comprise silica, Ag, Au, calcium phosphate or titanium dioxide or carbon or a carbon-based material. The nanoparticles may have a core having a diameter of from 100nm to 1000nm. The core may be a solid core or a hollow core. The nanoparticles have little or no porosity.
(mRNA).
Two or more nucleic acids may be used.
The silica precursor may comprise tetraethyl orthosilicate (TEOS), tetrapropyl orthosilicate (TPOS) or tetrabutoxysilane (TBOS), tetramethyl orthosilicate (TMOS) or other silica precursors known to those skilled in the art. Under the reaction conditions used, the silica precursor may form silica. Alternatively, the silica precursor may form a silicon containing material that may be subsequently converted to silica.
This allows the shell to form around the sacrificial particle. This shell will surround the hollow core in the final rough mesoporous hollow nanoparticle. In another embodiment, the shell material precursor forms material at a significantly faster rate than the precursors for the carbon-based material. This will also result in the formation of a shell around the sacrificial particle. However, formation of the carbon-based material from its precursors will still occur and this will tend to occur on the surface of the shell or silicon containing shell in competition with the deposition of further shell material. As a result, separate islands of carbon-based material and shell material will form on the surface of the shell. Further deposition of the carbon-based material will tend to occur on the islands of carbon-based material, leading to outgrowths of carbon-based material. Similarly, further deposition of the shell material will tend to occur on the islands of shell material, leading to outgrowths of the shell material. Thus, rod-like outgrowths of each material will occur. Once the shell material precursor has been exhausted, further carbon-based material will be deposited to form an outer shell of carbon-based material.
Removal of the carbon-based material, such as by calcination in air, results in the formation of the rough mesoporous hollow nanoparticles.
This silica or silicon containing shell will surround the hollow core in the final rough mesoporous hollow silica nanoparticle. In another embodiment, the silica precursor forms silica or silicon containing material at a significantly faster rate than the precursors for the carbon-based material. This will also result in the formation of a silica shell or silicon containing shell around the sacrificial particle. However, formation of the carbon-based material from its precursors will still occur and this will tend to occur on the surface of the silica shell or silicon containing shell in competition with the deposition of further silica or silicon containing material. As a result, separate islands of carbon-based material and silica/silicon containing material will form on the surface of the silica/silicon containing material shell. Further deposition of the carbon-based material will tend to occur on the islands of carbon-based material, leading to outgrowths of carbon-based material.
Similarly, further deposition of the silica/silicon containing material will tend to occur on the islands of silica/silicon containing material, leading to outgrowths of silica/silicon containing material. Thus, rod-like outgrowths of each material will occur. Once the silica precursor has been exhausted, further carbon-based material will be deposited to falai an outer shell of carbon-based material. Removal of the carbon-based material, such as by calcination in air, results in the formation of the rough mesoporous hollow silica nanoparticles.
Indeed, in some embodiments, the shell may comprise a discontinuous material layer or a relatively continuous interlinked material layer.
The silica or silicon containing material could be replaced by other materials, e.g. titanium dioxide derived from aluminium isopropoxide or aluminium oxide from titanium (IV) butoxide. The obtained nanoparticles can be N-doped compositions of carbon nanoparticles by replacing RF with aminophenol-formaldehyde or dopamine containing N as polymerisation precursors in alcohol-water system.
The bilayered morphology may comprise invaginated, endo-invaginated or intact spheres. The diameter of the carbon nanoparticle and hollow core size may range from 100-1000 nm, the thickness of the wall surrounding the hollow core may range from 5-100 nm. The pore volume and surface area of the bilayered carbon nanoparticles may be in the range of 1-3 cm3 g-1 and 800-1300 m2 g-1, respectively. The bilayered structure may comprise two spaced partial or complete carbon shells, with the inner shell being essentially hollow. The carbon particles may have a multi-layered structure, having 2 or more spaced partial or complete carbon shells.
Indeed, the present invention emcompasses any material known to be suitable for use as such by the person skilled in the art.
BRIEF DESCRIPTION OF DRAWINGS
images (e and f) of MSHSs-RS and MSHSs-SS;
and F are samples washed by water);
(pink in B is the DSC
curve for physical mixture of spinosad and silica nanoparticles);
irradiation;
adsorption branch (B) of the rough silica hollow spheres made in example 2;
wo 2016/164987 PCT/AU2016/050283 for 400 nm particles and d) The release behaviour of VAN for 200 nm particles.
The error bars reflect the standard deviation of the measurements.
* indicated 100% inhibition. The error bars reflect the standard deviation of the measurements. Scale bar =
500 nm (see example 3).
measurement;
(C), ET
reconstruction of invaginated MHCS (B) and intact MHCS (D). Scale bars are 100 nm;
(curve II), silica@RF
(curve III) and silica@RF@silica@RF (curve IV) as a function of reaction time;
orientation. Tilted TEM
images (B and C). Slice (D) cuts the YZ plane in the centre of the particle while silde(E) and slice (F) cut the XY plane at position a and b as indicated in diagram (A), respectively. Scale bars are 100 nm;
DESCRIPTION OF EMBODIMENTS
Development of a nano-pesticide with improved safety and performance.
Spinosad, a naturally derived pesticide with low environmental impact and low toxicity will be loaded into silica hollow spheres which will improve adhesion to skin/hair and protect against UV degradation. The nano-spinosad pesticide will have enhanced efficacy and effective duration in field conditions compared to conventional pesticides, significantly reducing the cost of pest control.
Adhesive property of nanoparticles on animal skin fur
Skin samples containing the nanoparticles were dissolved in 2M NaOH overnight under stirring to allow dissolution of the silica nanoparticles and silicon concentration were measured. Silicon amount of similar size skin without nanoparticles were also measured as the blank.
Preparation of nano-spinosad
Characterization
For FE-SEM measurements of nano-spinosad, the samples were directly attached to the conductive carbon film on SEM mounts. Transmission electron microscopy (TEM) images of the silica nanopartices were obtained with JEOL 2100 operated at 200 kV. For TEM
measurements, the samples were prepared by dispersing and drying the powder samples-ethanol dispersion on carbon film on a Cu grid. Fourier transform infrared (FTIR) spectra were collected on a ThermoNicolet Nexus 6700 FTIR spectrometer equipped with a Diamond ATR
(attenuated total reflection) Crystal. For each spectrum, 32 scans were collected at resolution of 4 cm-1 over the range 400-4000 cm-1. Wide angle X-ray diffraction (WA-XRD) patterns of the materials were recorded on a German Bruker D8 X-ray diffractometer with Ni-filtered Cu Ka Radiation. A
Metter Toledo GC200 thermogravimetric analysis (TGA) station was used for the loading amount and differential scanning caloiimetry (DSC) study at a heating rate of wo 2016/164987 PCT/AU2016/050283 Release test of nano-spinosad
The release amount of pure spinosad in water was also tested using the same procedure.
UV-stability test of nano-spinosad
The UV degradation conditions of both pure spinosad and nano-spinosad-0.4 were tested by high-performance liquid chromatography (HPLC) using ACN as the mobile phase.
In vitro bio-assay
Preparation of MSHSs-RS
The repulsion of the trapped air in the void spaces towards water molecules provides the energy barrier against the wetting process because the hydroxyl groups in silica tend to absorb water molecules, as in the case of MSHSs (as shown in Fig. lb). Therefore, the designed MSHSs-RS should demonstrate increased hydrophobicity compared to MSHSs although both materials have the same pure silica composition. It is also advantageous compared to a solid nanoparticle with a rough surface because the solid nanoparticle with a rough surface has less air pockets (no hollow core having a radius of R2) and limited loading capacity of hydrophobic drugs. Previous studies mainly focused on large flat surfaces; nanoparticles with hydrophilic compositions and hydrophobic properties through surface roughness control have not been reported and have not been demonstrated for bio-applications. Images of the prepared MSHSs-RS were taken using a scanning electron microscope (SEM) and a transmission electron microscope (TEM) (see Figs.
lc, le). For comparison MSHSs with a smooth surface were also prepared and characterised as shown in Figs. id and if. Both nanoparticles have uniform and hollow spherical morphology with the surface of MSHS-RS homogeneously decorated with silica shell particles. In accordance with our theory, MSHSs-RS nanoparticles show unusual hydrophobic properties.
Hydrophobicity was directly observed by the dispersion of nanoparticles in a mixed solvent of water/diethyl ether. MSHSs-RS preferentially rests at the bottom of the diethyl ether layer (a hydrophobic solvent) while MSHSs directly disperses in the water layer. TGA
profiles presented a small weight loss of 0.9% below 200 C for MSHSs-RS and 7.2% for MSHSs which can be attributed to the evaporation of moisture, indicating that the introduction of surface roughness makes MSHSs-RS more hydrophobic and thus it absorbs less moisture from the atmosphere than MSHSs.
have a contact angle value of 107.5 10 whilst that of MSHSs was 72.5 5. The contact angle value of MSHSs-RS is slightly lower than that obtained for the octadecyltrimethoxysilane modified silica (-136 ). Compared to MSHSs, MSHSs-RS exhibits consistently higher loading capacity for a range of hydrophobic molecules, including RNase A (RNASE), insulin (INS), lysozyme (LYS), a hydrophobic dye, disperse red 1 (DR1) and a hydrophobic drug, griseofulvin (GRIS).
These results further confirm that enhanced surface hydrophobicity of MSHS-RS
nanoparticles increases the loading capacity of hydrophobic molecules.
MSHSs-RS and MSHSs with the same weight were dispersed in water and homogeneously applied to two pieces of fur with the same size. After drying and washing with water three times, the silica content remaining on fur was measured. Fig. 2A is the optical image of kangaroo fur that illustrates typical hair structure. In comparison, pure silica shows white particles under optical microscope due to its powder nature (Fig. 2B). After application of silica nanoparticles onto the fur samples, white particles were observed attaching on the surface of the hairs, indicating the attachment of both silica nanoparticles (Figs 2C and 2D). After three times washing, there are more white wo 2016/164987 PCT/AU2016/050283 particles attached onto the kangaroo hairs than in the case of MSHSs-RS (fig 2E) compared to that of MSHSs-SS (fig 2F). This phenomenon indicates that MSHSs-RS have stronger adhesion ability on animal hairs. This conclusion is also supported from the ICPOES
results. The silica weight percentage remaining on fur for MSHSs and MSHSs-RS was 28.5% and 51.0%, respectively. MSHSs-RS shows significantly improved adhesion due to its rough surface and hydrophobicity. The enhanced adhesion of MSHSs-RS nanoparticles on fur should prolong the effective duration of Spinosad-MSHSs-RS nano-formulation in field conditions.
The nano-spinosad composites are denoted nano-spinosad-X where X stands for the ratio of spinosad and silica. Figure 3 shows the FTIR spectrum of pure spinosad with obvious characteristic peaks at 891, 987, 1041, 1099, 1213, 1263, 1371, 1456, 1660, 1707 and in the range of 2787-3012 cm-1. The spectrum of silica nanoparticles shows a characteristic peak at 810 cm-1 that can be attributed to v(Si-0), and broad peak in the range of 1050-1200 cm-1 that can be attributed to -Si-O-Si bonding. In the spectra of all nano-spinsad-X, characteristic peaks 1371, 1456, 1660, 1707 and in the range of 2787-3012 cm-1 can still be observed besides overlapping with the characteristic peaks of silica. The FTIR spectra confirm the successful encapsulation of spinosad with silica nanoparticles.
(X = 0.4, 0.5 and 0.6) is calculated to be 28.6, 33.3 and 37.5 %, respectively, indicating that rotary evaporation can achieve complete loading (- 100%) of spinosad.
(Fig. 4B). Pure spinosad displays a sharp endothermic peak at 129 C which indicates the melting point of crystalline spinosad. Similar to pure silica, all nano-spinosad-X show no wo 2016/164987 PCT/AU2016/050283 obvious peaks in the range of 25-350 C, indicating an amorphous state. In comparison, a small endothermic peak at 129 C is observed for the physical mixture of spinosad and silica (pink), indicating the existence of crystalline spinosad structure. The above results indicate that spinosad was encapsulated into MSHS-RS nanoparticles in a nano-dispersed form by utilizing the rotary evaporation technique.
These phenomena indicate the spinosad is successfully encapsulated in the cavity of MSHS-RS
nanoparticles in different feeding ratios.
On the other hand, for pure spinosad, only 2.4% of spinosad was released at 5 min while the cumulative release is less than 8% even at 540 min. Spinosad confined in silica nanoparticles shows a solubility of ¨ 0.2 mg/ml, which is more than two times higher than that of pure spinosad, similar to the solubility enhancement of curcumin confined inside mesoporous materials. Consequently, the release behaviour of spinosad is improved compared to the pure spinosad. The fast release of a higher concentration of spinosad is expected to be beneficial for the development of an "effective-immediately" nano-spinosad formulation.
which was used to monitor the product after UV treatment utilizing ACN as the extraction media and mobile phase. As shown in Figure 8, the peak at retention time of 3.5 mm is attributed to spinosad. An additional peak at retention time of 1.5 min was also observed in the pure spinosad group, which can be attributed to the degraded product. This observation is in accordance with literature reports, indicating spinosad itself is UV labile. However, in the nano-spinosad group, the degradation peak is not observed, suggesting that the silica shell has a protective effect against UV irradiation for spinosad loaded inside the nano-cavity.
These results indicate of nano-spinosad show comparable and slightly better toxicity to tick larval models. This result confirms that after encapsulation the spinosad loaded in silica nanoparticles is still effective.
nanoparticles with - 100 % loading. The loading amount can reach up to 28.6-37.5% (wt/wt) as determined by TGA analysis, while WA-XRD and DSC analysis confirmed that spinosad was dispersed in the nano-cavity of the MSHS-RS in an amorphous state.
Consequently, the release behaviour of spinosad is improved compared to the pure spinosad. Furthermore, the silica shell has a protective effect against UV irradiation for spinosad loaded inside the nano-cavity thus providing UV-shielding and protection of the labile spinosad. The nano-spinsad after loading in the cavity of the MSHS-RS is proved to be comparably effective to cattle tick larval (Rhipicephalus microplus). With enhanced water solubility, UV stability and fur adhesion of Spinosad-MSHSs-RS, this nanoformulation is expected to have prolonged duration of efficacy under field conditions.
EXAMPLE 2- Forming MSHS-RS
of ethanol, mL of water and 3mL of ammonia (28 wt%) with a pH about 11.5 to form resorcinol-formaldehyde (RF) nanospheres at room temperature with a diameter of 180 nm after 6h of polymerization. These RF nanospheres will form a sacrificial particle that will be eventually removed. Then, a certain amount of tetraethyl orthosilicate (TEOS) was added into the reaction solution, followed by another addition of resorcinol and formaldehyde 5minutes later in Step II. Due to the difference between silica and RF deposition rates in Step II, a triple-layered shell was formed on the preformed RF core spheres.
Specifically, a relatively dense silica layer was firstly deposited on the surface of preformed RF
spheres, because of the faster condensation speed of silica oligomers compared with RF oligomers.
Following passage of a certain time, when the RF oligomers started to polymerize, the intergrowth of RF along with the silica species started on the surface of the first silica layer, followed by a preferentially vertical growth of these two species. This resulted in the formation of hybrid second layer of 'rod-like' silica and RF. With the consumption of silica species, the remaining RF oligomers further deposited on the second layer to form an outmost layer of pure RF. By adjusting the amount of TEOS from 1.4 to 0.6 mL added in Step IT, the thickness of the first silica layer reduced and the distance between the 'rod-like' silica enlarged due to the decreasing condensation rate of silica species. It should be noted that, with only 0.6mL
of TEOS added, the first silica layer is not continuous with some crevices existed. This may result from the discrete distribution of silica nuclei on the pre-formed RF surface and slow growth before merging together to form a relatively continuous interlinked silica layer. After calcination in air in Step III, the RF species in the hybrid composites were removed, leaving the silica hollow spheres with rough surface. The final silica products are denoted as S-1.4, S-1.0 and S-0.6 where the number represents the volume amount of TEOS addition in Step IL
The representative transmission electron microscopy (TEM) images of S-1.4, S-1.0 and S-0.6 are shown in Figures 10A-10C. Monodispersed silica hollow sphere with rough surface were observed in all the samples. The average particle size of S-1.4, S-1.0 and S 0.6 is estimated to be 300, 280 and 250nm, respectively. The hollow cavity size of three samples is almost the same at about 160nm, which is relatively smaller than the size of preformed RF
nanospheres (180nm). This may be caused by shrinkage during calcination. The 'rod-like' rough structure on the shell can be clearly identified from the TEM images, and a decreasing density of silica 'rod' distribution on the shell can also be revealed. Dynamic light scattering (DLS) analysis was further utilized to determine the particle size and monodispersity. As shown in Fig.
10D, the hydrodynamic diameter of S-1.4, S-1.0 and S-0.6 is about 295, 310 and 325nm, respectively, which is slightly larger than those determined by TEM due to surrounded water molecules. The narrow particle size distribution curves with a small polydispersity index (PDI) value (0.053, 0.086, and 0.101 for S-1.4, S-1.0 and S-0.6 respectively) indicate all of the silica hollow spheres possess unifoim particle sizes and excellent monodispersity.
As shown in the l'E.M images shown in Figure 10, the 'rod-like' rough structure can be clearly identified, however, the first silica layer beneath it is hardly revealed, even though a higher contrast appeared inside of the silica shell. To further explore the detailed structures of those rough silica hollow spheres, an electron tomography (ET) technique was utilized by taking a tilted series from +700 to 70 with an increase step of 1 . The tomograms were obtained by processing the tilted images with lOnm Au fiducial alignment via IMOD. The tomogram slices referring to the middle part of the rough silica hollow spheres are shown as Figures 11 A-C. The silica shell observed from TEM images actually was composed of two layers, one relatively dense silica layer and another rough layer with 'rod-like' structures. The thickness of the dense silica layer decreased from 41nm in S-1.4 to 31nm in S-1.0, and even 19nm in S-0.6. The decreasing thickness may result from the slower silica condensation rate with less TEOS amount addition. Interestingly, the relatively dense silica shell in S-1.4 (Fig 11 A) and S-1.0 (Fig 11 B) are both continuous without any pore structures connecting the hollow cavity.
However, the one in S-0.6 showed several crevices with a width about 1-2 nm distributed on this layer (Fig 11 C, black arrows), which provided transport channels for small molecules to access the inner hollow space.
With enlarged distance between the silica 'rods', there are more of the spaces provided for the nitrogen molecules to condense, which will finally achieve a higher amount for adsorption (Ref Langmuir 1999, 15;8714). This is in accordance with the surface area and pore volume increase from 133m2/g and 0.19 cm3/g of S-1.4, to 167m2/g and 0.26 cm3/g of S-1.0, and 182m2/g and 0.37 cm3/g of S-0.6 with enlarged interstitial distance.
The increasing adsorption capacity should be attributed to the larger interstitial distance, rising pore volume and enhanced surface hydrophobicity introduced by the surface roughness, as well as the volume provided by the accessible hollow central cores of the spheres.
EXAMPLE 3 ¨ delivery systems for use in biological systems
Hydrophobic moieties such as alkanethiols and alkyl chains have been modified onto the surfaces of various nanoparticles including gold and silica to enhance the loading of hydrophobic drugs/protein and improve cellular delivery performance. However, chemically grafted hydrophobic groups tended to cause unwanted toxicity and pore blocking of nano-carriers. It is therefore a challenge to design a safe and efficient nanocarrier system employing an alternative approach.
Compared to rough solid Stoller (RSS) silica nanoparticles, rough mesoporous hollow spheres of silica (RMHS) provide more space to trap the air, leading to a higher energy barrier during the wetting process and thus more distinguished hydrophobicity. The nature of hydrophilic composition of RMHS
provides a high loading capacity of the 'last resort' antibiotic vancomycin (VAN) while the hydrophobic property facilitates the controlled release of VAN and adhesion to bacteria, resulting in enhanced antibacterial efficacy, compared to free VAN and MHS-VAN.
The surfaces of RMHS are homogeneously decorated with 40 nm silica nanospheres, indicating the successful attachment of silica nanospheres to the surface of MHS. In contrast, MHS
(Figure 2b, 2d) has an average particle size of 350 nm. HRTEM images (Figure 14c, 14d) clearly indicate the hollow core@porous shell structure of RMHS and MHS. The hollow core is -230 nm in diameter and the porous shell is about 60 nm in thickness. SEM images show the hollow core of the nanoparticles with monodisperse morphology for both MHS and RMHS. The hydrodynamic size of MHS and RMHS was further measured by dynamic light scattering (DLS), which shows a size of 396 nm for MHS and 459 nm for RMHS, consistent with both SEM and TEM
results.
The distance between two neighboring silica nanospheres is measured at around 30 nm and the gap between them provides space for the air entrapment.
The higher pore volume of RMHS (0.46 vs 0.31 cm3 g-1 of MHS) is mainly attributed to the inter-particle packing voids as reflected by the capillary condensation step which occurred at relative pressure (P/Po) higher than 0.95. Surface charge measurement by z-potential showed that both RMHS and MHS were negatively charged to a similar degree. Both samples have pure silica in composition as confirmed by Fourier transform infrared spectroscopy (FTIR), showing characteristic peaks for physisorbed water (-OH) at 1620 cm-1, silanol group (Si-OH) at 790cm-1, as well as siloxane group (Si-O-Si) at 1062 and 449 cm-1.
which can be attributed to the evaporation of moisture. The TGA results indicate that the introduction of surface roughness makes RMHS more hydrophobic and thus it absorbs less moisture from the atmosphere than MHS.
and RSS. The slope of this plot is proportional to the relative hydrophobicity of nanoparticles. Compared to RSS with the slope of 0.000675 x10-9 mL [tm-2, RMHS yielded higher slope value of 0.00106 x10-9 mL m2, indicating higher hydrophobicity of RMHS compared to RSS. MHS on the other hand showed the lowest slope with no significant value suggesting a hydrophilic nature.
wo 2016/164987 PCT/AU2016/050283
RMHS and MHS were used in the adsorption of three hydrophobic proteins including RNase A (RNASE), insulin (INS) and lysozyme (LYS) a hydrophobic dye, disperse red 1 (DR1) and a hydrophobic drug, griseofulvin (GRIS). As shown in Figure 15a, a higher loading capacity was achieved exclusively for five sorbates by RMHS than MHS.
Compared to MHS, a faster adsorption rate of DR1 (Figure 15b) and LYS was also observed when comparing RMHS to MHS. These results indicate that enhanced surface hydrophobicity of nanoparticles favours higher and faster loading of hydrophobic molecules. The loading capacity of RSS
towards LYS was also measured as 25.9 mg g-1. Compared to that of RMHS
(263.1mg/g), the much lower LYS loading amount of RSS can be attributed to its solid nature.
To further understand the role of air which induced RMHS hydrophobicity, the adsorption capacity of RMHS towards LYS was conducted in solutions after removing air bubbles under a vacuum condition. The adsorption amount of the LYS on RMHS was found to be reduced by 37.3% (from 263.1 mg g-1 to 172.1 mg g-1), comparable with the adsorption capacity of MHS (161.5 mg g-1). An additional experiment was conducted by eliminating the pre-sonication process to retain most of the air trapped by the nanoparticles.
Higher loading of LYS was achieved by RMHS without sonication with 27.5% increment compared to the adsorption using RHMS subject to pre-sonication steps in Figure 15a. These results confirmed the role of air as the hydrophobic solvent on the RMHS structure which subsequently improves the adsorption for protein. In contrast, surface roughness has no influence on the loading capacity of a hydrophilic molecule, VAN, as shown in Figure 4c. Similar loading value was achieved for both MHS and RMHS with this hydrophobic molecule. However, the hydrophobic property of RMHS enabled sustained release behaviour of VAN up to more than 36 h relative to 100% release at 8 h for MHS (Figure 15c).
The size of the core nanoparticles with similar morphology can be further finely tuned with the same preparation method. The inventors have successfully prepared MHS and RMHS with an average core size of 200 nm and 13 nm shell particles size named as MHS200 and RMHS200. Both nanoparticles have similar surface morphology compared to the larger particles (MHS and RMHS) as shown by TEM and SEM images. MHS200 and RMHS200 have slightly smaller pore size (3.4 nm) and relatively higher pore volume (0.38 cm3 for MHS200 and 0.62 cm3 g-1 for RMHS200) compared to the larger sized particles.
The use of nanoparticles as a delivery vehicle for antibiotics provides a promising strategy through prolonged drug circulation half-life, increased availability of drugs interacting with membrane molecules and promoted sustained drug release. VAN is an antibiotic useful for the treatment of a number of bacterial infections since it inhibits the cell wall synthesis in wo 2016/164987 PCT/AU2016/050283 susceptible bacteria. To demonstrate the antibacterial efficacy of VAN
delivered by the surface engineered materials, drug loaded nanoparticles were incubated with Escherichia coil (E. coli).
Nanoparticles with a size of 200 nm (MHS200 and RMHS200) were chosen in this study because the screen test showed that compared to larger particles (-400 nm), smaller ones exhibited higher bacterial toxicity effect. The in vitro antibacterial activity of VAN, MHS200-VAN and RMHS200-VAN was evaluated by monitoring the optical density (OD) at 600 nm of a bacterial suspension. E.coli (1 x 106 CFU mL-I) was incubated in Luria-Bertani (LB) medium in a 1.5 ml centrifuge tube at various concentrations of VAN for 18 h. The minimum inhibitory concentration (MIC) value of free VAN towards E.coli was observed at 25 jig mL-I (Figure 16a). This value reduced to 20 jig m1-1 for RMHS200-VAN
which is lower than the dosage used with VAN conjugated MCM-41 (200 jig m1-1) in in-vitro E-coli culture at 18 h. In a separate experiment, MHS200-VAN, RMHS200-VAN and free VAN with the same VAN content of 25 lig m1-1 were incubated with 1 x 106 CFU mL-I E.Coli in LB
media and OD
was measured as a function of time. It was observed that RMHS200-VAN
maintained 100%
inhibition throughout 24 h. However, re-growth of bacteria as evidenced by increases in OD was observed in both MHS200-VAN and free VAN groups after 18 h (Figure 16b).
should be attributed to two advantages coming from the nanoparticle design: 1) the rough surface particles have a higher efficacy compared to their smooth counterparts; and (2) the hydrophobic nature of RMHS200 which leads to a sustained release of VAN compared to MHS200 (Figure 16d), similar to the larger sized nanoparticles (Figure 16c). Eventually the effective time window of the drug is increased.
Compared to the untreated group, VAN treated bacteria showed damage of the bacterial membrane (Figure 16d-f). For MHS200-VAN, MHS200 was found in the bacterial membrane (Figure 16e) and severe damage of the wall/membrane of E.coli (Figure 16f) was clearly observed. The cell cytotoxicity of MHS200 and RMHS200 to normal human dermal fibroblast (HDF) was also assessed by the MTT assay. No significant cytotoxicity of both nanoparticles even at a concentration of up to 500 lig/mL was observed, providing evidence of excellent bio-inertness and safety of the materials as the carrier system.
wo 2016/164987 PCT/AU2016/050283
EXAMPLE 4 ¨ Preparation of Carbonaceous nanoparticles
concept is schematically illustrated in Figure 17. The synthesis is carried out in an ethanol/water system with NH34120 as the catalyst, simply using tetraethyl orthosilicate (TEOS), resorcinol and formaldehyde (RF) as precursors. In step I when TEOS and RF precursors are mixed together, Stober spheres are formed through a homogenous nucleation process due to the relatively faster condensation rate compared to the RF system. Once the silica spheres are formed, the RF
precursors preferentially condense on the silica surface through heterogeneous nucleation. In order to tune the wall structure, TEOS is introduced again in step IT. which forms uniformly distributed silica nanoparticles on the RF shell surface through a subsequent heterogeneous nucleation process. The residual RF oligomers further condense on the top of silica nanoparticles to create a second RF layer. After carbonization with or without hydrothermal treatment (step III) under inert atmosphere followed by the removal of silica (step IV), mesostructured hollow carbon spheres (MHCS) with a bilayered structure are obtained. By controlling the thickness of carbon/silica shells, the bilayered morphology (invaginated, endo-invaginated or intact spheres) and mesopore size can be finely regulated.
show a clearly bilayered and hollow internal structure (Fig. 18B). When MHCS
are prepared with hydrothermal treatment, an intact spheroidal morphology is obtained as shown by the SEM
image (Fig. 18C). TEM observations for these particles also show a bilayered concentric spherical structure (Fig. 18D).
18E). Dynamic light scattering (DLS) measurements reveal a hydrated particle size of 265 and 295 nm for invaginated and intact MHCSs, respectively (Fig. 18F). The narrow size distributions and low polydispersity index (PDI of 0.1) for two samples indicate both MHCS
possess highly uniform particle size and excellent water dispersibility. High resolution SEM
images reveal highly porous, rough external surfaces with open-pore entrances for the invaginated MHCS.
Intact MHCS on the other hand, exhibit relatively smooth and continuous surface morphology.
This is because TEM images provide the collective structural information over a certain thickness and merge it into a 2D projection. For example, the fine structures between the inner and outer layers are not clear. Moreover, it seems that two spheres shown in Fig. 18B
(indicated by arrows) are not invaginated, although this effect could result from the electron beam passing perpendicular to the plane of invagination. Electron tomography (ET) is a rapidly developing technique for the advanced 3D imaging of complex structures, which allows virtual reconstruction of a material's internal structure using 3D models built from a series of 2D slices (19, 20).
A series of tilted images was taken in the range of +70 to -70 with increments of 10.
Using this technique, one can clearly observe the invaginated MHCS particle apparently changing from an invaginated to an intact spherical structure. This highlights the ambiguity of the data provided by conventional TEM alone and confirms the importance of ET characterization for materials with complex and asymmetrical architectures. To observe the detailed internal structures of MHCS, electron tomograms were generated from two perpendicular tilting series using IMOD software (21). The ET slice which cuts perpendicular to the invagination face of the MHCS (Fig. 19A) exhibits a clearly bilayered, crescent moon-like morphology. The inner and outer layers are linked by thin carbon bridges of approximately 1-2 nm in thickness (indicated by black arrows).
In contrast, a tilt-series of the intact MHCS reveals a complete spherical morphology throughout the rotation (data not shown). The ET slide in Fig. 19C shows a full moon-like morphology for the intact MHCS, where the two concentric layers are linked by more substantial carbon bridges with approximately 4-5 nm in thickness.
Moreover, carbon bridges linking the inner and outer shell can also be observed for both invaginated and intact MHCS.
adsorption isotherms. The BJH pore sizes calculated from the adsorption branch indicate pore sizes of 15.9 and 18.0 nm for the invaginated and intact MHCS, respectively.
These pore sizes correspond closely with the measured interlayer distance between the inner and outer shells observed in ET and TEM micrographs, suggesting this confined interlayer space is responsible for the BJH pore size distribution. The BET surface area and pore volume of invaginated MHCS
(1032 m2 g-1 and 2.11 cm3 g-1, respectively) are slightly higher than those obtained for the intact MHCS (880 m2 g-1 and 1.44 cm3 g-1, respectively), which may be attributed to thinner shells and thus the increase in bulk-to-surface ratio for the more solidly constructed intact MHCS. The X-ray photoelectron spectra (XPS) show that only peaks from Cis (-285 eV) and 0 1 s (-534 eV) are detected, revealing the major components of both invaginated and intact MHCSs are carbon and oxygen (22). The mass percentage of carbon and oxygen are calculated to be 92.9 % and 7.1 %, respectively. The X-ray diffraction (XRD) patterns reveal the amorphous nature of MHCS.
Under the synthesis conditions utilised, the polymerization of TEOS results in formation of silica particles within 15 minutes (m), consistent with the typical induction period commonly observed in Stober sphere formation (23). These spheres then rapidly increase in size up to 2 h, after which particle size is relatively consistent. RF polymerization under the same conditions on the other hand, forms spheres with slower growth. The formation of some irregular RF
polymer nucleates is observable at 1 h, which continue developing into spherical particles by 2 h. The RF spheres wo 2016/164987 PCT/AU2016/050283 increase in size relatively rapidly from 2 to 6 h followed by a slower growth region till 12 h.
From curve II it can be inferred free RF oligorners persist in the synthetic system at 12 h.
reveals that the particle size initially (up to 1 h) follows the same trend as the pure silica system with only silica particles are formed. After 2 h the particle sizes increase gradually to 250 nm at 12 h, forming silica@RF core-shell structures with increasing RF shell thickness as a function of time. No evidence of solid RF spheres nor solid carbon spheres after carbonization/silica etching can be found, indicating that the RF polymerization system has been changed from homogeneous to heterogeneous nucleation on the surface of silica cores, consistent with classical nucleation theory that the free energy bather for heterogeneous nucleation on a surface is considerably lower as compared to homogeneous nucleation. However, this approach leads to hollow carbon spheres with only microporous walls, which has little control over the morphology and mesostructures of final products and thus limited applications.
was used to monitor the structural evolution over the following 2 h. From TEM
images of samples after calcination in air, it can be seen that a secondary population of silica nucleus appears on the surface of silica@RF particles within 15 m after the second TEOS addition. The secondary silica nanoparticles increase in size from -5 nm at 15 m up to -10 nm at 30 m before merging together to form a relatively continuous interlinked silica shell with a radial thickness of 18 nm at 2 h. After secondary TEOS addition, the particle size steadily increases (Fig. 20, curve IV) relative to the silica@RF particles shown in curve III, achieving an additional 30 nm in diameter after 12 h of growth. TEM data confirm the absence of any solid silica nanoparticles in the final products. The above observations indicate that the RF layer of silica@RF particles foinied in step I triggers a subsequent heterogeneous nucleation of TEOS. Due to the slower polymerization behavior of RF system, the remaining RF precursors preferentially nucleate on silica surface. The sequential heterogeneous nucleation of two polymerisable systems and their interplay gives rise to an interpenetrating silica-RF composite shell structure. Removing silica in the core and shell after carbonization results in the final structures of MHCS.
mechanism. The bridges in between two carbon layers come from the intergrowth of RF with secondary silica nanoparticles. Hydrothermal treatment favors further condensation of RF
system, leading to thicker bilayers as well as bridges and eventually intact MHCS. The invaginated MHCS with exposed porous surface are fonned due to the thinner RF
layers and bridges when hydrothermal treatment is not used in step III.
wo 2016/164987 PCT/AU2016/050283
was added at 24 h, only hollow microporous carbon structures with thickness of 15 nm are obtained. These results demonstrate that carefully controlling the polymerization kinetics and elaborately regulating the nucleation process of TEOS and RF precursors in sequence enables the foi niation of bilayered MHCS.
in the scheme). The results clearly demonstrate that when the thickness of single layered hollow carbon sphere is as thin as 5 nm, most particles show invaginated morphology.
With an increased thickness to 8 nm, only a small number of invaginated spheres can be observed, while an increase to 13 nm yields only intact spheres. This study demonstrates that the thickness of carbon layer plays a crucial role in controlling the invaginated or intact morphologies of the final products.
measurements. The general trend is that the samples without hydrothermal treatment exhibited much higher surface areas and pore volume than those with hydrothermal treatment, consistent with what we observed before. Moreover, the greater the distance between the shells, the higher the observed surface area and pore volume. This can be ascribed to the enlarged mesoporous interlayer region in samples with large interlayer spacing. The corresponding silica templates show increased sizes and continuity of silica shells with the increasing amount of TEOS added.
Figures 20B and 20C show two TEM images recorded along x- and z-axis (parallel and perpendicular to endo-invaginated plane), respectively. The ET slice shown in Fig. 21D reveals the cross-sectional crescent and spherical morphology of the inner and outer layers respectively along the yz plane right in the middle of the endo-invaginated structure. Two additional ET slices are given along the xy plane (Fig 21E and 21F) at z-height of a and b as indicated in Fig. 21A, respectively, showing two concentric rings and three concentric rings accordingly. Some carbon bridges can be observed connecting the outer-most ring to the middle ring (Figs. 21E and 21F).
The middle ring however, has no observable bridges connecting the inner-most ring, indicating that these two surfaces originally coming from the inner sphere are not fused.
These distinct structure features would be impossible to obtain using conventional characterization techniques other than ET.
For both invaginated and intact particles, around 75% of the saturation adsorption can be achieved within 10 minutes, suggesting fast adsorption kinetics towards lysozyme. The maximum adsorbed amount of lysozyme on the invaginated particles is around 1250 [tg mg-1 after 6 h, showing the highest adsorption capacity towards lysozyme compared to previous reports. The fast adsorption rate and high adsorption capacity should be attributed to the large entrance size, high surface area and the hydrophobicity of the invaginated MHCS.
Example 4: Demonstration of enhanced adhesion to bacterial cell walls
Here, by engineering surface roughness, MSHS-RS particles show enhanced bacterial adhesion properties, which may be attributed to the multivalent interactions induced by their surface spikes when contacting with the hairy bacteria surface, resulting in strong adhesion via a large number of contacts.
Extensive washing was applied to remove the isolated particles in the solution. Bacteria-free samples were also analyzed as a control and to eliminate the interference from aggregated silica particles. The ICP results (Figure 22d) show that less than 0.1 pg of MSHS-SS
particles adhere on each bacterial cell surface, whereas, 0.36 pg of MSHS-RS-B and 0.48 pg of MSHS-RS
particles remain on each bacteria.
Example 5: Formulation with lysozyme
particles show the lowest loading capacity of only 61 pg-mg-1 (jig lysozyme per mg of silica). In contrast, MSHS-RS particles exhibit the highest loading capacity of 270 ng=mg-1, which is two times of that achieved by MSHS-RS-B particles (135 pg.mg-1). This is attributed to the increase of mesopore volume from 0,117 (MSHS-RS-B) to 0.229 cm3.g-1 (MSHS-RS). The surface zeta potential of silica hollow spheres before and after lysozyme loading was characterized in 10 mM
phosphate buffer solution (PBS). After lysozyme loading, zeta potential of MSHS-SS particles changes dramatically from -29 mV to -3 mV, indicating the positive charged lysozyme is adsorbed on the external surface. However, for MSHS-RS-B and MSHS-RS
particles, their surface charge change from -19 mV and -18 mV to -8 mV and -6 mV, respectively.
This suggests that lysozyme molecules are typically immobilized into the mesopores of the MSHS-RS-B and MSHS-RS particles, resulting in limited neutralization of surface charge.
Example 6: Lysozyme release
Lysozyme release behaviour from the silica particles was examined under the condition with fixed initial lysozyme concentration (270 pg=mL-1) in PBS. MSHS-SS particles exhibit a boost release of lysozyme with more than 85% released within 18 h.
Compared to these smooth particles, MSHS-RS-B particles show a relatively slower release rate with around 75%
of lysozyme released after 24 h. MSHS-RS particles exhibit the most sustained release profile among three particles, with only 74% of lysozyme released at 72 h. However, MSHS-RS with a relatively large pore size are supposed to have a fast release profile. The retarded release of protein molecules from MSHS-RS may result from the enhanced surface hydrophobicity induced by the surface roughness and accessible inner cavity.
Example 7: Antibacterial activity of formulated lysozyme
The in vitro antibacterial activity of free lysozyme and lysozyme loaded silica particles formulated using the above procedure were compared by the optical density (OD) measurement. E. coli (5x106 CFLJ= mu') was incubated with various concentrations of lysozyme and corresponding lysozyme loaded silica particles for 24 h. Across all samples dose dependent antibacterial performance was observed wherein higher concentrations/loadings of lysozyme resulted in greater antibacterial activity. Lysozyme formulated into the silica particles showed higher activity compared to free lysozyme at the same lysozyme concentration and this effect is more significant at lysozyme concentration above 500 jig- mL-1. Rough silica particles exhibit enhanced antibacterial activity towards E. coli relative to free lysozyme and MSHS-SS particles especially for MSHS-RS particles, showing a minimum inhibitory concentration (MIC) value of 700 g-mL-1 for the latter. In contrast, the MIC of free lysozyme towards E.
coli cannot be achieved even at the concentration as high as 2 mg. mL-1.
To further demonstrate the advantages of the silica particles as lysozyme carriers, the long-term bacterial inhibition was tested via bacteria kinetic tests under batch culture. The time dependent bacterial growth at lysozyme concentration of 700 ptg.mL4 was monitored for 3 days (Figure 2b). LB-agar plate assay was employed to examine the bacterial viability after 3-day treatment. It was observed that MSHS-RS particles maintained 100% bacterial inhibition throughout the three day test. This three-day inhibition result is comparable to the performance of silver loaded silica nanoparticles at 80 ug=mL-1 as demonstrated by the bacterial kinetic assay.
In contrast, time dependent bacterial growth as evidenced by the increase of OD value is observed for MSHS-SS, MSHS-RS-B and free lysozyme formulations. No viable colonies can be observed on the agar plates for bacteria treated with lysozyme loaded MSHS-RS particles showing strong bactericidal activity of the silica particles as opposed to the other samples. The long-term bacterial inhibition property should be attributed to two advantages provided by the design of the silica particles: 1) enhanced adhesion to bacterial surface enabled by the surface roughness which results in efficient, targeted delivery of lysozyme and enriched local concentration of lysozyme on the bacterial surface, and 2) prolonged antimicrobial activity achieved by the sustained release of lysozyme from MSHS-RS particles. However, due to relatively weak particle-bacteria interaction and fast lysozyme release, MSHS-SS and MSHS-RS-B fail to control the bacterial growth with inadequate lysozyme concentration delivered efficiently towards the bacterial surface.
Example 8: Formulation of particles with ivermectin
analysis ivermectin formulations using MSHS-RS particles and hydrophobically modified MSHS-RS particles showed no significant degradation of ivermectin, indicating the ivettnectin composition was well protected by the nanoparticles.
Example 9: Varying the size of MSHS-RS particles
particles.
Samples SBET (m2/g) VTõtai (cm3/g) d pare (nm) resorcinol 0.15 g 178 0.434 12.1 resorcinol 0.30 g 227 0.548 16.5 resorcinol 0.45 g 268 0.665 16.5 resorcinol 0.60 g 275 0.831 16.5 Example 10: Formulation with p-DNA
molecules, thus cationic functional groups were introduced onto the silica particles to enhance the electrostatic attraction between p-DNA and the silica by coating the silica particles with polyethylenimine (PEI). After PEI modification, the silica particles still maintain their spiky topography. Nitrogen sorption results showed that PEI modified MSHS-RS particles exhibited mesoporous structures with pore size around 11 nm. The pore size can be enlarged to 16 and 19 nm by hydrothermal treatment at temperatures of 100 and 130 C respectively, and the hydrothermal treatment at 150 C can further enlarge the pore size with a wide distribution from 20 to 80 nm.
The zeta potential of these the MSHS-RS particles changes from negative (--20 to -30 mV) to positive (-1-15 mV) after PEI modification, indicating the successful introduction of PEI groups on the silica particle surface.
binding capacity (29.7 ng/m) than the PEI-modified MSHS-SS particles (14.7 ng/m). To be noted, MSHS-RS particles that has undergone hydrothermal treatment showed even larger p-DNA
loading capacity compared with the MSHS-RS particles without hydrothermal treatment due the wo 2016/164987 PCT/AU2016/050283 enlarged pore size and pore volume. In the gel retardation assay, a constant amount of pcDNA3-EGFP (0.5 jig) was mixed with various amounts of PEI modified silica particles from 0 to 80 pg.
Example 11: formulation of battery electrodes and battery cells
transmission electron microscope (TEM) image of SeS2/carbon is shown in Figure 25b. It is clearly seen that the contrast is higher in the interlayer space than in the hollow cavity. This difference is not observed in the TEM image of the bare particles (Fig. 25a), indicating that SeS2 predominately locates in the interlayer space between the two carbon shells rather than in the cavity. The underlying reason is possibly due to a higher capillary force in a smaller nano-space to attract SeS2, which explains our observation in trial experiments that single-layered carbon hollow spheres with microporous walls cannot load S/SeS2 in their cavity. Therefore, the choice of multi-layered hollow carbon such as the carbon of the present invention is essential in our design. The electrochemical evaluation suggests that the SeS2/carbon composite exhibits an excellent cycling stability, high specific capacity and high Coulombic efficiency (Fig. 25c). A
battery was constructed using the SeS2/carbon particles as the basis of the cathode and lithium metal was used as the anode. After 100 cycles, the reversible capacity still remains at 930 mAh/g with no capacity decay at 200 mA/g. The Coulombic efficiency levels off at 99.5 % from the 2nd cycle. For comparison, pure SeS2 shows a much inferior cycling performance.
The capacity decreases continuously throughout the cycling such that after 100 cycles a low capacity of 75 mAh/g is observed. These proof-of-concept results highlight that carbon spheres of the present invention are excellent hosts for SeS2 and the SeS2/carbon composites are promising electrode materials for next-generation Li-SeS, batteries.
Thus, the appearance of the phrases 'in one embodiment' or 'in an embodiment' in various places throughout this specification are not necessarily all referring to the same embodiment.
Furthermore, the particular features, structures, or characteristics may be combined in any suitable manner in one or more combinations.
Claims (17)
wherein the size of the projections ranges from 5 nm to 1000 nm; and wherein the projections comprise strands or cylinders or fibres extending outwardly from the mesoporous shell of the rough mesoporous hollow silica nanoparticles.
Date Recue/Date Received 2022-06-01
Date Recue/Date Received 2022-06-01
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2015901379 | 2015-04-17 | ||
| AU2015901379A AU2015901379A0 (en) | 2015-04-17 | Composition, particulate materials and methods for making particulate materials. | |
| PCT/AU2016/050283 WO2016164987A1 (en) | 2015-04-17 | 2016-04-18 | Composition, particulate materials and methods for making particulate materials. |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2980957A1 CA2980957A1 (en) | 2016-10-20 |
| CA2980957C true CA2980957C (en) | 2023-08-08 |
Family
ID=57125461
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2980957A Active CA2980957C (en) | 2015-04-17 | 2016-04-18 | Composition, particulate materials and methods for making particulate materials. |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US11345599B2 (en) |
| EP (2) | EP3283435B1 (en) |
| JP (1) | JP6910954B2 (en) |
| CN (1) | CN107614430B (en) |
| AU (1) | AU2016250296B2 (en) |
| CA (1) | CA2980957C (en) |
| DK (2) | DK3283435T3 (en) |
| ES (2) | ES2908677T3 (en) |
| PL (2) | PL3283435T3 (en) |
| PT (2) | PT3659590T (en) |
| WO (1) | WO2016164987A1 (en) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3634909A4 (en) * | 2016-06-10 | 2021-02-17 | The University of Queensland | MESOPOROUS DENDRITIC SILICA NANOPARTICLES SYNTHEIZED VIA AN EASY MONOTOPE PROCESS |
| CN109564218B (en) | 2016-06-10 | 2022-08-19 | 昆士兰大学 | Detecting analytes |
| IL254053B (en) * | 2016-08-19 | 2021-03-25 | Univ Nat Taiwan | Hollow silica nanoparticles with encapsulated bioactive ingredients, preparation process and applications thereof |
| CN110612323A (en) * | 2017-01-19 | 2019-12-24 | 石墨烯技术公司 | Multifunctional nanocomposites reinforced with impregnated honeycomb carbon nanostructures |
| CN110506026B (en) | 2017-03-15 | 2024-03-08 | 迪金森公司 | Composite containing unimpregnated cellular carbon nanostructures |
| EP3632849B1 (en) * | 2017-05-31 | 2022-07-06 | JGC Catalysts and Chemicals Ltd. | Hollow particles and cosmetics containing them |
| CN109212202A (en) * | 2017-07-07 | 2019-01-15 | 中科新蕴生物科技(北京)有限公司 | Peroxidase activity of nitrogen-doped nanometer carbon ball and application thereof |
| US20200129444A1 (en) * | 2017-07-13 | 2020-04-30 | Carnegie Mellon University | Method of Increasing Epithelial Permeability Using Nanoparticles |
| GB201718817D0 (en) * | 2017-11-14 | 2017-12-27 | N4 Pharma Uk Ltd | Particulate material production process |
| CN108039486A (en) * | 2017-12-20 | 2018-05-15 | 湖南工业大学 | The hollow core shell structure vanadic anhydride anode electrode piece of tremelliform and its fastening lithium ionic cell preparation method |
| WO2019159866A1 (en) * | 2018-02-15 | 2019-08-22 | 花王株式会社 | Human hair fiber treatment agent |
| US11130679B2 (en) | 2018-03-06 | 2021-09-28 | University Of Utah Research Foundation | Biodegradable hollow nanoparticles and methods and apparatus for manufacturing the same |
| CN108675261B (en) * | 2018-06-01 | 2019-12-27 | 徐州医科大学 | Gold nanosheet modified carbon fiber SERS substrate material and preparation method and application thereof |
| US12201956B2 (en) * | 2018-10-16 | 2025-01-21 | Pharma In Silica Laboratories Inc. | Tunable process for silica capsules/spheres preparation and their use |
| CN109330991B (en) * | 2018-11-09 | 2021-08-06 | 上海交通大学医学院附属第九人民医院 | Traditional Chinese medicine nano-medicament and preparation method and application thereof |
| US11414658B2 (en) * | 2018-12-25 | 2022-08-16 | Industrial Technology Research Institute | Tracer particle and method of using the same and method of manufacturing the same |
| EP3955737A1 (en) * | 2019-04-17 | 2022-02-23 | Adolphe Merkle Institute, University of Fribourg | Method of production of controlled release silica nanoparticles for plant growth and/or defense enhancement |
| US20230355662A1 (en) * | 2019-06-19 | 2023-11-09 | Zylo Therapeutics, Inc. | Sulfur functionalized monoliths and particles derived from the same as nitric oxide carriers for pharmaceutical and cosmetic applications |
| CN112151728B (en) * | 2019-06-28 | 2022-04-15 | 比亚迪股份有限公司 | Lithium ion battery composite diaphragm, preparation method thereof and lithium ion battery |
| CN110639440A (en) * | 2019-09-24 | 2020-01-03 | 中国海洋大学 | Preparation method of carbon/silicon dioxide composite microspheres |
| CN110663685B (en) * | 2019-10-23 | 2021-10-12 | 扬州大学 | Mesoporous silica supported PPTE nano pesticide preparation |
| CN110975812B (en) * | 2019-12-18 | 2022-03-01 | 西北农林科技大学 | A kind of tea saponin hollow carbon sphere and its preparation method and application in heavy metal adsorption |
| GB202005957D0 (en) * | 2020-04-23 | 2020-06-10 | N4 Pharma Uk Ltd | Transfection and transduction system |
| CN111592801A (en) * | 2020-06-04 | 2020-08-28 | 广东省生物工程研究所(广州甘蔗糖业研究所) | A slow-release coating, a slow-release mulch film and a preparation method thereof |
| CN114074936B (en) * | 2020-08-21 | 2023-07-21 | 中国科学院福建物质结构研究所 | A kind of nitrogen-doped carbon nanosphere and its preparation method and application |
| JP2023541834A (en) | 2020-09-09 | 2023-10-04 | ディッキンソン コーポレーション | Scalable synthesis of enveloped mineral carbon |
| US11712655B2 (en) | 2020-11-30 | 2023-08-01 | H2 Powertech, Llc | Membrane-based hydrogen purifiers |
| CN113113606B (en) * | 2021-04-08 | 2023-04-07 | 昆山宝创新能源科技有限公司 | Negative electrode material, preparation method thereof, pole piece and lithium ion battery |
| CN113443633B (en) * | 2021-06-28 | 2022-04-29 | 上海千溯生物科技有限公司 | Small-size kernel viroid-like silica nanoparticle and preparation method thereof |
| CN113264535B (en) * | 2021-06-28 | 2021-12-31 | 上海千溯生物科技有限公司 | Silicon dioxide nano particle with bent spikes and preparation method thereof |
| CN113620258B (en) * | 2021-07-14 | 2022-11-01 | 江苏晨牌邦德药业有限公司 | A kind of shampoo, dandruff, itching and cleaning agent additive |
| GB202110646D0 (en) * | 2021-07-23 | 2021-09-08 | Sisaf Ltd | Nucleic acid vector compositions |
| CN113620288B (en) * | 2021-09-01 | 2022-10-11 | 合肥水泥研究设计院有限公司 | A kind of multifunctional biological drying conditioner and preparation method thereof |
| CN115885989B (en) * | 2022-10-20 | 2024-05-03 | 河北农业大学 | Sustained-release pyrethroid nanoparticle and preparation method and application thereof |
| EP4507037A4 (en) * | 2022-11-15 | 2025-11-05 | Contemporary Amperex Technology Hong Kong Ltd | Negative electrode film and manufacturing process therefor, secondary battery and electrical device |
| KR102736072B1 (en) * | 2023-05-15 | 2024-12-05 | 주식회사 엠피오스 | Silica-based nanoparticle for sustained-releasing of hydrophobic drug and method of manufacturing the same and transdermal drug delivery system comprising the same |
| EP4670507A1 (en) | 2024-06-27 | 2025-12-31 | Agrana Beteiligungs- Aktiengesellschaft | METHOD FOR CONTROLLING OR PREVENTING SOURCE BEETLE INFESTATIONS |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7758888B2 (en) | 2000-04-21 | 2010-07-20 | Sol-Gel Technologies Ltd. | Composition exhibiting enhanced formulation stability and delivery of topical active ingredients |
| EP1335693A2 (en) * | 2000-04-21 | 2003-08-20 | Sol-Gel Technologies Ltd. | Composition exhibiting enhanced formulation stability and delivery of topical active ingredients |
| US6913825B2 (en) * | 2001-09-20 | 2005-07-05 | University Of Notre Dame Du Lac | Process for making mesoporous silicate nanoparticle coatings and hollow mesoporous silica nano-shells |
| CN1247455C (en) * | 2002-12-30 | 2006-03-29 | 新加坡纳米材料科技有限公司 | Silicon dioxide mesoporous material and its preparing method |
| KR100544886B1 (en) * | 2003-08-06 | 2006-01-24 | 학교법인 대전기독학원 한남대학교 | Electrocatalyst for Fuel Cell and Manufacturing Method of Electrocatalyst Supported by HMC Carbon Capsule Structure |
| KR100551602B1 (en) * | 2003-08-14 | 2006-02-13 | 한남대학교 산학협력단 | HMC capsule structure containing metal nanoparticles in the hollow and its manufacturing method |
| KR20060018200A (en) * | 2004-08-23 | 2006-02-28 | 김진만 | Short-turn inline skating |
| US7309830B2 (en) * | 2005-05-03 | 2007-12-18 | Toyota Motor Engineering & Manufacturing North America, Inc. | Nanostructured bulk thermoelectric material |
| CN101058824A (en) | 2006-04-21 | 2007-10-24 | 北京化工大学 | Immobilized enzyme biological catalyst, preparation method and application |
| US8202614B2 (en) * | 2006-08-09 | 2012-06-19 | Luna Innovations Incorporated | Additive particles having superhydrophobic characteristics and coatings and methods of making and using the same |
| AU2008254646A1 (en) | 2007-05-21 | 2008-11-27 | Aquea Scientific Corporation | Highly charged microcapsules |
| EP2167209A4 (en) * | 2007-07-18 | 2013-03-06 | Univ Nanyang Tech | HOLLOW POROUS MICROSPHERES |
| WO2009023697A2 (en) | 2007-08-14 | 2009-02-19 | The Regents Of The University Of California | Hollow silica nanospheres and methods of making same |
| CN101391776B (en) | 2007-09-21 | 2011-01-12 | 中国科学院理化技术研究所 | Preparation method of porous silicon dioxide nanosphere with special structure on surface and porous silicon dioxide nanosphere |
| KR100932979B1 (en) | 2007-11-28 | 2009-12-21 | 삼성에스디아이 주식회사 | Hollow capsule structure and manufacturing method thereof |
| CN102112219A (en) * | 2008-07-31 | 2011-06-29 | 溶胶凝胶技术公司 | Microcapsules comprising active ingredients and metal oxide shell, method for their preparation and uses thereof |
| WO2010046286A1 (en) | 2008-10-24 | 2010-04-29 | Basf Se | Method for the manufacture of microparticles comprising an effect substance |
| KR101011525B1 (en) * | 2009-03-30 | 2011-01-31 | 한국표준과학연구원 | Manufacturing method of porous hollow capsule |
| CN101708853B (en) | 2009-07-08 | 2013-03-27 | 济南大学 | Hollow silicon dioxide microsphere with different surface configurations and preparation method thereof |
| WO2011133925A2 (en) * | 2010-04-23 | 2011-10-27 | Massachusetts Institute Of Technology | Targeted and light-activated cytosolic drug delivery |
| GB201019434D0 (en) | 2010-11-17 | 2010-12-29 | Isis Innovation | Sonosensitive nanoparticles |
| KR101259867B1 (en) | 2011-01-05 | 2013-05-02 | 광주과학기술원 | A absorbent comprising hydrophobic mesoporous material for removal of harmful pharmaceuticals from aqueous environment |
| WO2013007354A1 (en) * | 2011-07-08 | 2013-01-17 | Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V. | A method for preventing or reducing the production of biofilms formed by microorganisms using nanostructured surfaces |
| JP2013082599A (en) * | 2011-10-13 | 2013-05-09 | Nagoya Institute Of Technology | Hollow silica nanoparticle complexed with nanoparticle and production method thereof |
| CN102437318B (en) | 2011-11-30 | 2014-11-26 | 奇瑞汽车股份有限公司 | Preparation method for silicon-carbon composite material, prepared silicon-carbon composite material, lithium ion battery anode containing silicon-carbon composite material and battery |
| CN102530969B (en) * | 2012-02-10 | 2014-01-01 | 中国科学院上海硅酸盐研究所 | Preparation method of functionalized modified hollow mesoporous or core/shell mesoporous silica nanoparticles |
| MX2014011384A (en) * | 2012-03-23 | 2015-03-09 | Celanese Eva Performance Polymers Inc | Controlled release insect repellent materials. |
| US9126840B2 (en) * | 2013-05-29 | 2015-09-08 | Korea University Research And Business Foundation | Thioether-bridged organic/inorganic composite and method for preparing hollow or porous carbon structures and silica structures using the same |
| CN104445214A (en) * | 2014-11-03 | 2015-03-25 | 东华大学 | Mesoporous silica nano hollow sphere and preparation method thereof |
-
2016
- 2016-04-18 CN CN201680028237.8A patent/CN107614430B/en active Active
- 2016-04-18 PT PT201530557T patent/PT3659590T/en unknown
- 2016-04-18 ES ES20153055T patent/ES2908677T3/en active Active
- 2016-04-18 EP EP16779347.0A patent/EP3283435B1/en active Active
- 2016-04-18 CA CA2980957A patent/CA2980957C/en active Active
- 2016-04-18 PL PL16779347T patent/PL3283435T3/en unknown
- 2016-04-18 DK DK16779347.0T patent/DK3283435T3/en active
- 2016-04-18 PT PT167793470T patent/PT3283435T/en unknown
- 2016-04-18 DK DK20153055.7T patent/DK3659590T3/en active
- 2016-04-18 PL PL20153055T patent/PL3659590T3/en unknown
- 2016-04-18 ES ES16779347T patent/ES2885868T3/en active Active
- 2016-04-18 WO PCT/AU2016/050283 patent/WO2016164987A1/en not_active Ceased
- 2016-04-18 EP EP20153055.7A patent/EP3659590B1/en active Active
- 2016-04-18 JP JP2017550594A patent/JP6910954B2/en active Active
- 2016-04-18 US US15/567,249 patent/US11345599B2/en active Active
- 2016-04-18 AU AU2016250296A patent/AU2016250296B2/en active Active
-
2022
- 2022-04-27 US US17/730,820 patent/US12017917B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| ES2908677T3 (en) | 2022-05-03 |
| CA2980957A1 (en) | 2016-10-20 |
| EP3659590A1 (en) | 2020-06-03 |
| US20180105422A1 (en) | 2018-04-19 |
| EP3283435A4 (en) | 2018-11-21 |
| ES2885868T3 (en) | 2021-12-15 |
| CN107614430A (en) | 2018-01-19 |
| WO2016164987A1 (en) | 2016-10-20 |
| US12017917B2 (en) | 2024-06-25 |
| US11345599B2 (en) | 2022-05-31 |
| DK3283435T3 (en) | 2021-09-13 |
| EP3283435B1 (en) | 2021-06-09 |
| AU2016250296B2 (en) | 2021-02-25 |
| EP3283435A1 (en) | 2018-02-21 |
| JP2018516830A (en) | 2018-06-28 |
| PL3283435T3 (en) | 2021-11-08 |
| CN107614430B (en) | 2021-11-23 |
| US20220388846A1 (en) | 2022-12-08 |
| EP3659590B1 (en) | 2021-12-22 |
| JP6910954B2 (en) | 2021-07-28 |
| PT3283435T (en) | 2021-08-16 |
| PL3659590T3 (en) | 2022-04-04 |
| AU2016250296A1 (en) | 2017-11-02 |
| PT3659590T (en) | 2022-02-01 |
| DK3659590T3 (en) | 2022-03-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12017917B2 (en) | Composition, particulate materials and methods for making particulate materials | |
| Xie et al. | Tuning the bandgap of photo-sensitive polydopamine/Ag3PO4/graphene oxide coating for rapid, noninvasive disinfection of implants | |
| Hanif et al. | Halloysite nanotubes as a new drug-delivery system: a review | |
| Wang et al. | Kinetically controlled dendritic mesoporous silica nanoparticles: from dahlia-to pomegranate-like structures by micelle filling | |
| Victor et al. | Supramolecular hydroxyapatite complexes as theranostic near-infrared luminescent drug carriers | |
| Sharmiladevi et al. | Synthesis of mesoporous silica nanoparticles and drug loading for gram positive and gram-negative bacteria | |
| Cao et al. | Antimicrobial materials based on photothermal action and their application in wound treatment | |
| US11130679B2 (en) | Biodegradable hollow nanoparticles and methods and apparatus for manufacturing the same | |
| Obireddy et al. | Synthesis and properties of alginate-based nanoparticles incorporated with different inorganic nanoparticulate modifiers for enhanced encapsulation and controlled release of favipiravir | |
| Choudhury et al. | Methods for nanoparticle synthesis and drug delivery | |
| Rajak et al. | Antimicrobial activity of nanomaterials | |
| Gao et al. | Synthesis of carbon dot-ZnO-based nanomaterials for antibacterial application | |
| Chesneau et al. | Cerium oxide particles: coating with charged polysaccharides for limiting the aggregation state in biological media and potential application for antibiotic delivery | |
| Gwon et al. | Fabrication of silicon-based nickel nanoflower-encapsulated gelatin microspheres as an active antimicrobial carrier | |
| Özakar et al. | Preparation, characterization of chitosan-coated/uncoated boron nanoparticles and in-vitro evaluation of their antimicrobial effects | |
| Ranjbar et al. | Preparation of polyacrylamide/polylactic acid co-assembled core/shell nanofibers as designed beads for dapsone in vitro efficient delivery | |
| Suh | Use of natural halloysite as a functional cosmetics carrier | |
| Zhang et al. | MoS 2/Au–Ag@ PEG nanosheets with plasmonic coupling effect-enhanced NIR-II photothermal therapy and silver ion release for combined treatment of MRSA infection | |
| Yu et al. | Dipolar-hollowed α-Fe2O3@ Au/Polydopamine nanospindle for photothermal-photodynamic coupling antibacterial and drug-delivery | |
| Das et al. | Silica Nanoparticle for the Treatment of Bacterial Infections | |
| Karthikeyan et al. | Emerging Trends in Nanoparticle Biosynthesis and Their Application as a Novel Biomaterial | |
| da Silva Abreu et al. | Fabrication of polyelectrolyte microspheres using porous manganese carbonate as sacrificial template for drug delivery application | |
| Phan et al. | Doxycycline loaded Fe3O4 based nanocomposites: preparation and evaluation on growth and survival of white leg shrimp (Litopenaeus vannamei) | |
| Sang et al. | Metal Coordination Nanomedicine | |
| Peng et al. | Controllable pH-responsive hollow dendritic mesoporous bioactive glass nanocarriers for sustained doxorubicin release |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20210223 |
|
| MPN | Maintenance fee for patent paid |
Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 9TH ANNIV.) - STANDARD Year of fee payment: 9 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20250407 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20250407 |
|
| MPN | Maintenance fee for patent paid |
Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 10TH ANNIV.) - STANDARD Year of fee payment: 10 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20260407 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20260407 |